EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy

Angela Sandri, Maria Carelli, Alessandro Visentin, Alessia Savoldi, Gelinda De Grandi, Massimo Mirandola, Maria M Lleo, Caterina Signoretto, Maddalena Cordioli

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1155451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Angela Sandri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Sexual and Gender Minorities, Sexually Transmitted Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycoplasma genitalium (MG) is one of the most warning emerging sexually transmitted pathogens also due to its ability in developing resistance to antibiotics. MG causes different conditions ranging from asymptomatic infections to acute mucous inflammation. Resistance-guided therapy has demonstrated the best cure rates and macrolide resistance testing is recommended in many international guidelines. However, diagnostic and resistance testing can only be based on molecular methods, and the gap between genotypic resistance and microbiological clearance has not been fully evaluated yet. This study aims at finding mutations associated with MG antibiotic resistance and investigating the relationship with microbiological clearance amongst MSM.

Methods

From 2017 to 2021, genital (urine) and extragenital (pharyngeal and anorectal swabs) biological specimens were provided by men-who-have-sex-with-men (MSM) attending the STI clinic of the Infectious Disease Unit at the Verona University Hospital, Verona, Italy. A total of 1040 MSM were evaluated and 107 samples from 96 subjects resulted positive for MG. Among the MG-positive samples, all those available for further analysis (n=47) were considered for detection of mutations known to be associated with macrolide and quinolone resistance. 23S rRNA, gyrA and parC genes were analyzed by Sanger sequencing and Allplex™ MG and AziR Assay (Seegene).

Results

A total of 96/1040 (9.2%) subjects tested positive for MG in at least one anatomical site. MG was detected in 107 specimens: 33 urine samples, 72 rectal swabs and 2 pharyngeal swabs. Among them, 47 samples from 42 MSM were available for investigating the presence of mutations associated with macrolide and quinolone resistance: 30/47 (63.8%) showed mutations in 23S rRNA while 10/47 (21.3%) in parC or gyrA genes. All patients with positive Test of Cure (ToC) after first-line treatment with azithromycin (n=15) were infected with 23S rRNA-mutated MG strains. All patients undergoing second-line moxifloxacin treatment (n=13) resulted negative at ToC, even those carrying MG strains with mutations in parC gene (n=6).

Conclusion

Our observations confirm that mutations in 23S rRNA gene are associated with azithromycin treatment failure and that mutations in parC gene alone are not always associated with phenotypic resistance to moxifloxacin. This reinforces the importance of macrolide resistance testing to guide the treatment and reduce antibiotic pressure on MG strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumSexual and Gender MinoritiesSexually Transmitted DiseasesMaleHumansAnti-Bacterial AgentsMoxifloxacinAzithromycinHomosexuality, MaleFluoroquinolonesRNA, Ribosomal, 23SMacrolidesDrug Resistance, BacterialMutationGenitaliaPrevalence

Stichwörter der Autor:innen

Mycoplasma genitaliummacrolide resistancemen-who-have-sex-with-menquinolone resistancesexually transmitted infection

Substanzen

Anti-Bacterial AgentsMoxifloxacinAzithromycinFluoroquinolonesRNA, Ribosomal, 23SMacrolides

Autor:innen und Institutionen

  • Microbiology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • School of Health Statistics and Biometrics, University of Verona, Verona, Italy.
  • Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • School of Health Sciences, University of Brighton, Brighton, United Kingdom.

Zitieren

APA

Sandri, A., Carelli, M., Visentin, A., Savoldi, A., De Grandi, G., Mirandola, M., Lleo, M. M., Signoretto, C., & Cordioli, M. (2023). Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1155451

Vancouver

Sandri A, Carelli M, Visentin A, Savoldi A, De Grandi G, Mirandola M, et al. Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1155451

BibTeX
@article{Sandri2023,
  author = {Sandri, Angela and Carelli, Maria and Visentin, Alessandro and Savoldi, Alessia and De Grandi, Gelinda and Mirandola, Massimo and Lleo, Maria M and Signoretto, Caterina and Cordioli, Maddalena},
  title = {Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1155451}
}
Kostenlos starten →